-
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma
Study
EGAS50000001217
-
Targeted panel sequencing of two patient-derived melanoma cell lines
Dataset
EGAD50000001745
-
WES dataset of a TIL-ACT metastatic melanoma cohort
Dataset
EGAD50000001731
-
Health Information National Trends Survey-SEER (HINTS-SEER)
Study
phs004065
-
Methylproteome profiling of Diffuse Midline Glioma
Study
EGAS00001007342
-
Total proteome and phosphoproteome profiling of Diffuse Midline Glioma
Study
EGAS00001007341
-
Analysis of Large Cell Neuroendocrine Carcinoma Expressing HNF4alpha Using WGS
Study
JGAS000732
-
Genetic mutation profiling of lymphomas arising in the uterine cervix and vagina
Study
JGAS000823
-
Spatial Transcriptomic Analysis (Xenium in situ) of Large Cell Neuroendocrine Carcinoma
Study
JGAS000733
-
cfDNA methylation profiling on longitudinally collected blood plasma of patients with esophageal adenocarcinoma
Dataset
EGAD50000000734
-
Dynamics of checkpoint receptors in γδ T cell subsets are associated with clinical responses during anti-PD-1 immunotherapies
Dataset
EGAD50000001812
-
Spatial transcriptomics analysis of triple negative breast cancers
Study
EGAS50000000475
-
Visium CytAssist Spatial Gene Expression analysis for glioblastoma
Dataset
EGAD50000001767
-
DAC policy The Kids Research Institute Australia
Dac
EGAC50000000734
-
NHLBI TOPMed: African American Sarcoidosis Genetics Resource
Study
phs001207
-
Somatic L1 retrotransposition mapping in high-grade serous ovarian carcinoma using LDI-PCR/Nanopore-sequencing (part 2)
Dataset
EGAD50000001757
-
Convergent evolution towards CD38 biallelic loss is a recurrent mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
Study
EGAS50000000709
-
Single cell atlas of relapsed/refractory large B-cell lymphoma
Study
EGAS50000001293
-
MorphoITH: A Framework for Deconvolving Intra-Tumor Heterogeneity Using Tissue Morphology
Study
EGAS50000001064
-
Extrachromosomal DNA-driven oncogene dosage heterogeneity determines therapy response in neuroblastoma
Study
EGAS50000001040
-
ecDNA copy number heterogeneity
Study
EGAS50000000509
-
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma - RNA validation cohort
Study
EGAS50000001212
-
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma - WGS validation cohort
Study
EGAS50000001211
-
DAC for "Drug Development against Tumor Microtube Networks in Glioblastoma"
Dac
EGAC50000000326
-
Drug Development against Tumor Microtube Networks in Glioblastoma
Study
EGAS50000000477